相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Predictors of Long-term Outcomes in Patients With Connective Tissue Disease Associated With Pulmonary Arterial Hypertension
Kazuhiko Nakayama et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2021)
Safety and efficacy of rituximab in systemic sclerosis (DESIRES): a double-blind, investigator-initiated, randomised, placebo-controlled trial
Satoshi Ebata et al.
LANCET RHEUMATOLOGY (2021)
Interleukin-6 blockade with tocilizumab increases Tregs and reduces T effector cytokines in renal graft inflammation: A randomized controlled trial
Sindhu Chandran et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2021)
Serum markers of pulmonary epithelial damage in systemic sclerosis-associated interstitial lung disease and disease progression
Carmel J. W. Stock et al.
RESPIROLOGY (2021)
Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial
Kristin B Highland et al.
Lancet Respiratory Medicine (2021)
Nutritional status and quality of life in interstitial lung disease: a prospective cohort study
Alisar A. Kanjrawi et al.
BMC PULMONARY MEDICINE (2021)
Tocilizumab Prevents Progression of Early Systemic Sclerosis-Associated Interstitial Lung Disease
David Roofeh et al.
ARTHRITIS & RHEUMATOLOGY (2021)
Long-Term Outcomes in Patients With Connective Tissue Disease-Associated Pulmonary Arterial Hypertension in the Modern Treatment Era: Meta-Analyses of Randomized, Controlled Trials and Observational Registries
Dinesh Khanna et al.
ARTHRITIS & RHEUMATOLOGY (2021)
Treatment for systemic sclerosis-associated interstitial lung disease
David Roofeh et al.
CURRENT OPINION IN RHEUMATOLOGY (2021)
Real-world experience of tocilizumab in systemic sclerosis: potential benefit on lung function for anti-topoisomerase-positive patients
Yasir Suleman et al.
RHEUMATOLOGY (2021)
Performance of the DETECT Algorithm for Pulmonary Hypertension Screening in a Systemic Sclerosis Cohort
Amber Young et al.
ARTHRITIS & RHEUMATOLOGY (2021)
B Cell Depletion Inhibits Fibrosis Via Suppression of Profibrotic Macrophage Differentiation in a Mouse Model of Systemic Sclerosis
Hiroko Numajiri et al.
ARTHRITIS & RHEUMATOLOGY (2021)
Clinical characteristics, visceral involvement, and mortality in at-risk or early diffuse systemic sclerosis: a longitudinal analysis of an observational prospective multicenter US cohort
Sara Jaafar et al.
ARTHRITIS RESEARCH & THERAPY (2021)
Assessment of recent evidence for the management of patients with systemic sclerosis-associated interstitial lung disease: a systematic review
Anna-Maria Hoffmann-Vold et al.
ERJ OPEN RESEARCH (2021)
Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator-Initiated, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial
Dinesh Khanna et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Using Transitional Changes on High-Resolution Computed Tomography to Monitor the Impact of Cyclophosphamide or Mycophenolate Mofetil on Systemic Sclerosis-Related Interstitial Lung Disease
Grace Hyun J. Kim et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Using Autoantibodies and Cutaneous Subset to Develop Outcome-Based Disease Classification in Systemic Sclerosis
Svetlana I. Nihtyanova et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease
Dinesh Khanna et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Predictors of progression in systemic sclerosis patients with interstitial lung disease
Oliver Distler et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Management of systemic sclerosis: the first five years
David Roofeh et al.
CURRENT OPINION IN RHEUMATOLOGY (2020)
Performance Characteristics of Pulmonary Function Tests for the Detection of Interstitial Lung Disease in Adults with Early Diffuse Cutaneous Systemic Sclerosis
Elana J. Bernstein et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial
Dinesh Khanna et al.
LANCET RESPIRATORY MEDICINE (2020)
Osteopontin Links Myeloid Activation and Disease Progression in Systemic Sclerosis
Xia Gao et al.
CELL REPORTS MEDICINE (2020)
Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial
Lorinda Chung et al.
LANCET RHEUMATOLOGY (2020)
Analysis of body mass index, weight loss and progression of idiopathic pulmonary fibrosis
Stephane Jouneau et al.
RESPIRATORY RESEARCH (2020)
Treatment With Mycophenolate and Cyclophosphamide Leads to Clinically Meaningful Improvements in Patient-Reported Outcomes in Scleroderma Lung Disease: Results of Scleroderma Lung Study II
Elizabeth R. Volkmann et al.
ACR OPEN RHEUMATOLOGY (2020)
The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements
Anna-Maria Hoffmann-Vold et al.
LANCET RHEUMATOLOGY (2020)
Treatment of systemic sclerosis-associated interstitial lung disease: Lessons from clinical trials
David Roofeh et al.
JOURNAL OF SCLERODERMA AND RELATED DISORDERS (2020)
Emerging targets of disease-modifying therapy for systemic sclerosis
Elizabeth R. Volkmann et al.
NATURE REVIEWS RHEUMATOLOGY (2019)
Management of systemic sclerosis-associated interstitial lung disease
David Roofeh et al.
CURRENT OPINION IN RHEUMATOLOGY (2019)
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease
Oliver Distler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Single-cell analysis reveals fibroblast heterogeneity and myofibroblasts in systemic sclerosis-associated interstitial lung disease
Eleanor Valenzi et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
K. R. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts
Elizabeth R. Volkmann et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
M1/M2 polarisation state of M-CSF blood-derived macrophages in systemic sclerosis
Alain Lescoat et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Radiographic fibrosis score predicts survival in systemic sclerosis-associated interstitial lung disease
Reoto Takei et al.
RESPIROLOGY (2018)
Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis
Christopher P. Denton et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Distinct Properties of Human M-CSF and GM-CSF Monocyte-Derived Macrophages to Simulate Pathological Lung Conditions In Vitro: Application to Systemic and Inflammatory Disorders with Pulmonary Involvement
Alain Lescoat et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
KL-6 But Not CCL-18 Is a Predictor of Early Progression in Systemic Sclerosis-related Interstitial Lung Disease
Gloria A. Salazar et al.
JOURNAL OF RHEUMATOLOGY (2018)
Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma
K. M. Sullivan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
The Scleroderma Patient-Centered Intervention Network Cohort: baseline clinical features and comparison with other large scleroderma cohorts
Dane H. Dougherty et al.
RHEUMATOLOGY (2018)
Intravenous cyclophosphamide vs rituximab for the treatment of early diffuse scleroderma lung disease: open label, randomized, controlled trial
Geetabali Sircar et al.
RHEUMATOLOGY (2018)
Efficacy of Mycophenolate Mofetil and Oral Cyclophosphamide on Skin Thickness: Post Hoc Analyses From Two Randomized Placebo-Controlled Trials
Rajaie Namas et al.
ARTHRITIS CARE & RESEARCH (2018)
Brief Report: Smoking in Systemic Sclerosis: A Longitudinal European Scleroderma Trials and Research Group Study
Veronika K. Jaeger et al.
ARTHRITIS & RHEUMATOLOGY (2018)
Diagnosis of Idiopathic Pulmonary Fibrosis An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Lung transplantation in scleroderma: recent advances and lessons
Renea Jablonski et al.
CURRENT OPINION IN RHEUMATOLOGY (2018)
Longitudinal Changes in Quantitative Interstitial Lung Disease on Computed Tomography after Immunosuppression in the Scleroderma Lung Study II
Jonathan G. Goldin et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2018)
The evidence of benefits of exercise training in interstitial lung disease: a randomised controlled trial
Leona M. Dowman et al.
THORAX (2017)
Mapping and predicting mortality from systemic sclerosis
Muriel Elhai et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
An Open-label, Phase II Study of the Safety and Tolerability of Pirfenidone in Patients with Scleroderma-associated Interstitial Lung Disease: the LOTUSS Trial
Dinesh Khanna et al.
JOURNAL OF RHEUMATOLOGY (2016)
Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial
Dinesh Khanna et al.
LANCET (2016)
Impaired quality of life in systemic sclerosis and patient perception of the disease: A large international survey
Camelia Frantz et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2016)
Combination therapy versus monotherapy for pulmonary arterial hypertension: a meta-analysis
Annie Christine Lajoie et al.
LANCET RESPIRATORY MEDICINE (2016)
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial
Donald P. Tashkin et al.
LANCET RESPIRATORY MEDICINE (2016)
Mycophenolic acid reverses TGF beta-induced cell motility, collagen matrix contraction and cell morphology in vitro
Darinka Todorova Petrova et al.
CELL BIOCHEMISTRY AND FUNCTION (2015)
Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis
Lutz Wollin et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features
Aryeh Fischer et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
A consensus document for the selection of lung transplant candidates: 2014-An update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation
David Weill et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2015)
Pulmonary Function Tests: High Rate of False-Negative Results in the Early Detection and Screening of Scleroderma-Related Interstitial Lung Disease
Yossra A. Suliman et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Survival of Adults With Systemic Sclerosis Following Lung Transplantation A Nationwide Cohort Study
Elana J. Bernstein et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Report of the first international consensus on standardized nomenclature of antinuclear antibody HEp-2 cell patterns 2014-2015
Edward K. L. Chan et al.
FRONTIERS IN IMMUNOLOGY (2015)
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study
J. Gerry Coghlan et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Predictors of Mortality and Progression in Scleroderma-Associated Interstitial Lung Disease A Systematic Review
Tiffany A. Winstone et al.
CHEST (2014)
An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease
Anne E. Holland et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin
Jan Mauer et al.
NATURE IMMUNOLOGY (2014)
Prediction of Pulmonary Complications and Long-Term Survival in Systemic Sclerosis
Svetlana I. Nihtyanova et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Survival and Causes of Death in an Unselected, and Complete Cohort of Norwegian Patients with Systemic Sclerosis
Anna-Maria Hoffmann-Vold et al.
JOURNAL OF RHEUMATOLOGY (2013)
Does C-Reactive Protein Predict the Long-Term Progression of Interstitial Lung Disease and Survival in Patients With Early Systemic Sclerosis?
Xiaochun Liu et al.
ARTHRITIS CARE & RESEARCH (2013)
Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations
Philip H. Quanjer et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
An Official ATS/ERSARS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Autologous Hematopoietic Stem Cell Transplant in Systemic Sclerosis: Quantitative High Resolution Computed Tomography of the Chest Scoring
David Launay et al.
JOURNAL OF RHEUMATOLOGY (2009)
Interstitial lung disease in systemic sclerosis - A simple staging system
Nicole S. L. Goh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Oral Cyclophosphamide for Active Scleroderma Lung Disease: A Decision Analysis
Dinesh Khanna et al.
MEDICAL DECISION MAKING (2008)
Cyclophosphamide versus placebo in scleroderma lung disease
Donald P. Tashkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome
D Bouros et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Mycophenolate mofetil and its mechanisms of action
AC Allison et al.
IMMUNOPHARMACOLOGY (2000)
分享论文
